Bio-Rad Q4 Revenues Spike 5 Percent | GenomeWeb

This story has been updated from a previous version to include comments from Bio-Rad's earnings call.

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories reported after the close of the market today a 5 percent increase in fourth quarter revenues, driven by high-single-digit growth for its Life Science business.

The Hercules, Calif.-based company reported $602.6 million in revenues for the three months ended Dec. 31, 2013, up from $573.8 million a year ago, easily surpassing the average analyst estimate of $586.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.